This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Biobanking Remove Genotype Remove Life Science
article thumbnail

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

FEBRUARY 4, 2021

Biobanks are used for the coordination of high-yield patient sample collection. Moreover, biobanks are no longer passive biorepositories for accrual of samples and serve a more utilitarian function in identifying and coordinating specific research cohorts for longitudinal and prospective studies. Biobanking Models.

Research 98
Research Biobanking Drugs Genomics 98
article thumbnail

HFpEF vs. HFrEF: How To Improve Heart Failure Drug Development

XTalks

APRIL 15, 2021

Since both studies involved participants from the UK Biobank, Dr. Tyl and colleagues used a version of the HERMES data which excluded those from the UK cohort to avoid overlapping data. Genuity Science Drug Target Discovery Study. Using Deep Clinical Data and WGS to Better Subtype Heart Failure Patients.

Development 95
Development Drugs Genomics Genome 95
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 21,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024